NEW YORK (GenomeWeb News) — Bio-Rad Laboratories today said it has licensed Axis-Shield’s early-detection rheumatoid arthritis test.
 
Bio-Rad said the Axis-Shield assay, which is based on anti-CCP antibodies, will run on its BioPlex 2200 system.
 
The BP2200 is an automated multiplexing system that works at a rate of 2,200 results per hour. The platform already holds several assays designed for other autoimmune diseases.
 
Financial terms of the agreement were not released.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers in China have generated mouse pups from same-sex parents, according to Scientific American.

Two research teams find a role for PIEZO2 in touch sensitivity after injury and inflammation.

The South China Morning Post reports that Hong Kong plans to add HK$20 billion (US$2.6 billion) to a research endowment.

In Science this week: open genetic genealogy databases can lead to the identification of individuals who have not sought testing, and more.